MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ALKS — Alkermes Inc. plc

Nasdaq

Alkermes Inc. plc

Back to Screener
$40.54
+0.02(+0.05%)
O
40.00
H
41.41
L
39.99
V
2.28M
⏱️ End-of-day dataAs of Oct 1, 2026

Chart

About ALKS

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 16, 1991
Employees2,050
Stock ExchangeNasdaq
Ticker SymbolALKS

Key Financial Statistics

Market Cap$6.85B
P/E RatioN/A
Dividend YieldN/A
EPSN/A
BetaN/A
52-Week Range$0.94 - $98.50
52-Week Avg Volume1.02M
VWAP$40.68
Transactions27,421
Total Recorded Bars8,866 days